CONSIDERATION OF A NORTH AMERICAN HEROIN-ASSISTED CLINICAL TRIAL FOR THE TREATMENT OF OPIATE-DEPENDENT INDIVIDUALS
Uloženo v:
KUO, I., ET AL., CONSIDERATION OF A NORTH AMERICAN HEROIN-ASSISTED CLINICAL TRIAL FOR THE TREATMENT OF OPIATE-DEPENDENT INDIVIDUALS. INTERNATIONAL JOURNAL OF DRUG POLICY, THE, Vol. 11, no. 5 (2000), p. 357-370.
Ref.
91723
Umístění:
SIIS R.1114
Palabras clave:
Drogodependencias, Evolución, Experiencias, Experimentación, Heroína, Opiáceos, Programas de mantenimiento, Recomendaciones, Tratamiento médico, EE.UU.
Drogodependencias, Evolución, Experiencias, Experimentación, Heroína, Opiáceos, Programas de mantenimiento, Recomendaciones, Tratamiento médico, EE.UU.
Podobné jednotky: CONSIDERATION OF A NORTH AMERICAN HEROIN-ASSISTED CLINICAL TRIAL FOR THE TREATMENT OF OPIATE-DEPENDENT INDIVIDUALS
- THE EFFECT OF MOTIVATIONAL STATUS ON TREATMENT OUTCOME IN THE NORTH AMERICAN OPIATE MEDICATION INITIATIVE (NAOMI) STUDY
- NAOMI: THE TRIALS AND TRIBULATIONS OF IMPLEMENTING A HEROIN ASSISTED TREATMENT STUDY IN NORTH AMERICA
- NON-OPIOID INDUCTION OF MORPHINE-6-GLUCURONIDE SYNTHESIS IS ELICITED BY PROLONGED EXPOSURE OF RAT HEPATOCYTES TO HEROIN
- SURVEY OF DOCTORS PRESCRIBING DIAMORPHINE (HEROIN) TO OPIATE-DEPENDENT DRUG USERS IN THE UNITED KINGDOM
- ESCALATING MORPHINE EXPOSURES FOLLOWED BY WITHDRAWAL IN FELINE IMMUNODEFICIENCY VIRUS-INFECTED CATS: A MODEL FOR HIV INFECTION IN CHRONIC OPIATE ABUSERS
- UTILITY OF CROSSOVER DESIGNS IN CLINICAL TRIALS: EFFICACY OF DESIPRAMINE VS. PLACEBO IN OPIOID-DEPENDENT COCAINE ABUSERS